Prof. Feng Jiang 蒋峰
Chief Physician, Professor
Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Conventional and minimally invasive surgery for lung cancer, esophageal cancer, cardia cancer, and mediastinal tumors. Comprehensive treatment centered on surgery for lung and esophageal cancers.
Dr. Jiang holds a medical doctorate and completed postdoctoral training. Designated as a Jiangsu Province Medical Leading Talent, Dr. Jiang studied at the University of Alberta Faculty of Medicine in Canada. Dr. Jiang has led seven national and provincial research projects, published over 20 academic papers, and received six awards, including the Chinese Medical Science and Technology Award.
Name order: in Chinese the family name comes first (Jiang Feng). Papers usually list the name as Feng Jiang or Jiang F.
Selected publications
92 papers on PubMed matched by name and affiliation; 43 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Med, 2026 (senior author): Single-cell RNA sequencing analysis of bone cancer pain model induced by Lewis lung cancer cells in male mice. PubMed 41758238
- Cancer Med, 2026 (senior author): Discordant Primary Tumor and Nodal Response After Neoadjuvant Chemoimmunotherapy Identifies an Adverse Postoperative Subgroup in Esophageal Squamous Cell Carcinoma. PubMed 42989514
- PLOS Digit Health, 2026 (senior author): AI-driven dual-task prediction model for co-stratifying efficacy and toxicity in NSCLC immunotherapy. PubMed 42594060
- Tissue Eng Regen Med, 2026 (senior author): hsa_circ_0008758 Activates the MDM2/FOXO3a/PGK1 Pathway Through the miR-361-3p/SPIN1 Axis to Promote the Warburg Effect of Non-Small Cell Lung Cancer. PubMed 42484961
- Cancer Lett, 2026 (senior author): A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells. PubMed 41707977
- J Transl Med, 2026 (senior author): Integration of habitat radiomics and traditional radiomic features for predicting pathological complete response in esophageal squamous cell carcinoma following neoadjuvant immunotherapy and chemotherapy: a multicenter comparative study. PubMed 41530793
- Cell Rep, 2025 (senior author): circATF6 triggers calcium overload to synergize with EGFR-TKI in non-small cell lung cancer via modulation of proteostasis. PubMed 41351835
- Cell Death Dis, 2025 (senior author): The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer. PubMed 41213916
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion